it may be of therapeutic value in the treatment of conditions where inhibition of gastric acid secretion is desirable , e.g. , gastric and duodenal ulcer , and in conditions responding to cytoprotection , e.g. , stress ulcers , hemorrhagic gastritis and gastric erosions associated with nonsteroidal antiinflammatory drugs .
C0038351
gastric
C0400807
stress ulcers